A revolutionary new drug will soon be able to treat the 2.8 million Americans who suffer from debilitating migraines.
The Food and Drug Administration (FDA) has just approved a treatment called Aimovig, which is the first ever drug that is designed specifically to treat migraines.
Aimovig is applied through a monthly injection that works similarly to insulin shots. The medication then blocks a protein fragment called CGRP, which stimulates migraines.
Up until now, migraine patients have tried to treat and prevent the debilitating episodes by taking medication that is designed to treat other conditions, such as high blood pressure. According to the New York Times, however, these medications work very inconsistently. In addition to only offering partial relief and prevention, they often come with almost unbearable side effects.
RELATED:…
